- Investing Ideas
- U.S. Pharmaceuticals & Biotech Buy the Dip
U.S. Pharmaceuticals & Biotech Buy the Dip
Results
3
Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.
3 companies
Liquidia
Market Cap: US$6.1b
A biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States.
LQDA
US$70.27
7D
-9.6%
1Y
167.7%
Structure Therapeutics
Market Cap: US$3.5b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$49.01
7D
-8.8%
1Y
163.9%
Kodiak Sciences
Market Cap: US$2.4b
A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.
KOD
US$37.22
7D
-9.2%
1Y
293.0%